# Multiple Ascending Dose Study of TD-1439 in Healthy Adult and Elderly Subjects

> **NCT02954263** · PHASE1 · COMPLETED · sponsor: **Theravance Biopharma** · enrollment: 40 (actual)

## Conditions studied

- Healthy Adults, Elderly Subjects

## Interventions

- **DRUG:** TD-1439
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02954263
- **Lead sponsor:** Theravance Biopharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2017-02
- **Final completion:** 2017-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02954263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02954263, "Multiple Ascending Dose Study of TD-1439 in Healthy Adult and Elderly Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02954263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*